MarketCap
Facebook
X
TelegramAnnual report 2026
added 03-03-2026
STAAR Surgical Company Total Shareholders Equity 2011-2026 | STAA
Annual Total Shareholders Equity STAAR Surgical Company
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 344 M | 397 M | 386 M | 336 M | 262 M | 160 M | - | 132 M | 42.9 M | 37.9 M | 37.1 M | 38.9 M | - | 31.7 M | 29.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 397 M | 29.5 M | 172 M |
Quarterly Total Shareholders Equity STAAR Surgical Company
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 354 M | 337 M | 350 M | 397 M | 428 M | 409 M | 393 M | 386 M | 379 M | 358 M | 343 M | 336 M | 323 M | 299 M | 276 M | 259 M | 249 M | 235 M | 214 M | 160 M | 186 M | 175 M | 165 M | - | 149 M | 144 M | 137 M | 132 M | 132 M | 132 M | 132 M | 42.9 M | 42.9 M | 42.9 M | 42.9 M | 37.9 M | 37.9 M | 37.9 M | 37.9 M | 37.1 M | 39.5 M | 39.8 M | 36.3 M | 38.9 M | 40.6 M | 41.8 M | 41.3 M | - | 37.8 M | 34.7 M | 32.6 M | 31.7 M | 31.7 M | 31.7 M | 31.7 M | 29.5 M | 29.5 M | 29.5 M | 29.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 428 M | 29.5 M | 157 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
Alcon
ALC
|
18.8 B | $ 75.4 | -0.8 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 11.21 | -1.41 % | $ 27.2 M | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 63.09 | -1.94 % | $ 12.6 B | USA |
 |
ICU Medical
ICUI
|
2.12 B | $ 121.01 | -1.5 % | $ 2.98 B | USA |
 |
iRhythm Technologies
IRTC
|
153 M | $ 125.44 | -0.41 % | $ 4.01 B | USA |
 |
Haemonetics Corporation
HAE
|
821 M | $ 59.84 | -1.06 % | $ 3.01 B | USA |
 |
electroCore
ECOR
|
-1.71 M | $ 6.15 | 1.32 % | $ 52.2 K | USA |
 |
Repro Med Systems
KRMD
|
17 M | $ 4.08 | 0.49 % | $ 188 M | USA |
 |
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
17.8 B | $ 466.64 | -0.92 % | $ 167 B | USA |
 |
Microbot Medical
MBOT
|
77.6 M | $ 2.1 | -3.23 % | $ 96.2 M |  Israel |
 |
Glaukos Corporation
GKOS
|
462 M | $ 119.63 | -2.0 % | $ 5.79 B | USA |
 |
Milestone Scientific
MLSS
|
2.81 M | $ 0.33 | -4.15 % | $ 27.1 M | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 178.51 | -0.08 % | $ 9.51 B | USA |
 |
InfuSystem Holdings
INFU
|
48 M | $ 10.18 | -4.5 % | $ 210 M | USA |
 |
Merit Medical Systems
MMSI
|
1.58 B | $ 66.74 | -1.02 % | $ 3.95 B | USA |
 |
Envista Holdings Corporation
NVST
|
3.11 B | $ 26.49 | -1.05 % | $ 4.45 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 21.83 | -3.62 % | $ 1.47 B | USA |
 |
Retractable Technologies
RVP
|
74.4 M | $ 0.62 | -2.99 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 51.51 | -0.87 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
394 M | $ 112.4 | -1.85 % | $ 2.54 B | USA |
 |
STERIS plc
STE
|
6.6 B | $ 219.75 | -1.1 % | $ 21.7 B | USA |
 |
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | USA |
 |
Teleflex Incorporated
TFX
|
3.12 B | $ 135.52 | 0.33 % | $ 6.05 B | USA |
 |
BioLife Solutions
BLFS
|
349 M | $ 20.9 | -2.38 % | $ 963 M | USA |
 |
Stereotaxis
STXS
|
13.5 M | $ 1.86 | -3.63 % | $ 169 M | USA |
 |
Baxter International
BAX
|
6.13 B | $ 17.94 | -2.97 % | $ 9.2 B | USA |
 |
ResMed
RMD
|
3.36 B | $ 217.14 | -2.2 % | $ 31.7 B | USA |
 |
AtriCure
ATRC
|
492 M | $ 28.48 | -1.93 % | $ 1.36 B | USA |
 |
Utah Medical Products
UTMD
|
119 M | $ 66.61 | -0.25 % | $ 216 M | USA |
 |
Harvard Bioscience
HBIO
|
13.7 M | $ 6.45 | -5.56 % | $ 286 M | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
3.18 B | $ 292.13 | -3.33 % | $ 21.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.78 | -1.51 % | $ 2.35 B | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 10.98 | -0.99 % | $ 449 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25.4 B | $ 149.52 | -0.47 % | $ 43 B | USA |
 |
Nephros
NEPH
|
8.36 M | $ 3.32 | 2.79 % | $ 34.5 M | USA |
 |
OraSure Technologies
OSUR
|
341 M | $ 3.01 | - | $ 221 M | USA |
 |
Repligen Corporation
RGEN
|
1.96 B | $ 117.43 | -0.73 % | $ 6.54 M | USA |